| Revenue growth | 15% YoY for FY26 |
|---|---|
| Margins | Adj. EBITDA margin expanded 68 bps to 18.5% |
| Demand visibility | Healthy patient volumes across clusters |
| Management confidence | Strong trajectory of margin improvement |
Growth
FY26 Revenue up 15%, Adj. EBITDA up 19%, and ROCE improved to 14.0% from 13.0% YoY.
Outlook
Divesting Milann fertility business; expanding with 200+ brownfield beds and new North Bangalore MR-LINAC facility.
Risks
Moderation in East cluster ARPP due to clinical transitions; softer international patient contributions in South.
Earnings Call filed with BSE, NSE: HCG. Summary written with AI assistance from the document.
Healthcare Global Enterprises Ltd: key numbers
- Share price
- ₹698.65
- Market cap
- ₹10,431 Cr
- Revenue (annual)
- ₹2,545 Cr
- Net profit (annual)
- ₹13.76 Cr
- P/E (TTM)
- 457.5×Sector 57.8×
- Promoter holding
- 64.21%+0.00% QoQ
- FII holding
- 2.73%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Healthcare Global Enterprises Ltd
All →Healthcare Global Enterprises Annual General Meeting
HealthCare Global Enterprises held its 28th Annual General Meeting on September 18, 2026, via video conferencing to transact business items listed in the notice.
Healthcare Global Enterprises Employee Stock Options
HealthCare Global Enterprises Limited granted 64,46,843 employee stock options under its ESOS 2026 scheme. The grant carries an exercise price of INR 495 per share.
Healthcare Global Enterprises Earnings Call Transcript: Key Takeaways
HCG reported a strong Q1FY27 with 13% YoY revenue growth and 20% EBITDA growth, driven by volume and improved payor mix.
Healthcare Global Enterprises Investor Presentation: Key Takeaways
HCG reported strong Q1 FY27 results with 13% YoY revenue growth and 20% Adjusted EBITDA growth. Strategic focus on oncology and capacity expansion through a new North Bengaluru facility.
Healthcare Global Enterprises Q1 FY27 Results: Net Profit ₹16.5 Cr, Up 175.0% YoY
Healthcare Global Enterprises Ltd reported revenue from operations of ₹693.4 Cr (+13.3% YoY) and net profit of ₹16.5 Cr (+175.0% YoY) for Q1 FY27.
- Key figure
- Net profit ₹16.5 Cr · +175.0% YoY
Healthcare Global Enterprises Earnings Call: Key Takeaways
HCG delivered strong FY26 performance with 15% revenue growth and margin expansion. Strategy focuses on oncology core through the sale of fertility unit Milann and brownfield expansion.